Zevalin Price Negotiations Will Be Model For Medicare Part B, Scully Says

Idec's experience securing Medicare reimbursement for Zevalin should be considered the model for how coverage decisions will work for new products once Part B payment reforms are implemented in 2005, former CMS Administrator Tom Scully said